Pages that link to "Q54588060"
Jump to navigation
Jump to search
The following pages link to Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. (Q54588060):
Displaying 17 items.
- Structural Characterization of the Stem–Stem Dimerization Interface between Prolactin Receptor Chains Complexed with the Natural Hormone (Q27664687) (← links)
- Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism (Q33658181) (← links)
- Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes (Q33740398) (← links)
- Benign breast diseases (Q34555984) (← links)
- What can we learn from rodents about prolactin in humans? (Q34721567) (← links)
- Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors (Q36278252) (← links)
- Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports (Q36331355) (← links)
- Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse (Q36629985) (← links)
- Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors (Q36936457) (← links)
- Transgenic models to study actions of prolactin in mammary neoplasia. (Q37064926) (← links)
- Rational design of competitive prolactin/growth hormone receptor antagonists (Q37064937) (← links)
- Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation. (Q37192034) (← links)
- Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer (Q37302064) (← links)
- Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone (Q37358800) (← links)
- TRIENNIAL LACTATION SYMPOSIUM: Prolactin: The multifaceted potentiator of mammary growth and function1,2 (Q37972125) (← links)
- Autocrine/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview. (Q38275316) (← links)
- Development of prolactin receptor antagonists with reduced pH-dependence of receptor binding (Q58210999) (← links)